Literature DB >> 23061579

Introduction: The Health Care Reform Law (PPACA): controversies in ethics and policy.

Robert M Sade1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23061579      PMCID： PMC4489407          DOI： 10.1111/j.1748-720X.2012.00684.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN： 1073-1105            Impact factor:   1.718


× No keyword cloud information.
  9 in total

1.  The dénouement of the Supreme Court's ACA drama.

Authors:  Renée M Landers
Journal:  N Engl J Med       Date:  2012-07-02       Impact factor: 91.245

2.  Justice and fairness: a critical element in U.S. health system reform.

Authors:  Paul T Menzel
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

3.  Cost-sharing under consumer-driven health care will not reform U.S. health care.

Authors:  John P Geyman
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

4.  Government intervention in health care markets is practical, necessary, and morally sound.

Authors:  Len M Nichols
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

5.  No theory of justice can ground health care reform.

Authors:  Griffin Trotter
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

6.  Market-based reforms in health care are both practical and morally sound.

Authors:  James Stacey Taylor
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

7.  Medical responsibility.

Authors:  Ronald Hamowy
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

8.  Physicians have a responsibility to meet the health care needs of society.

Authors:  Allan S Brett
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

9.  Expanding choice through defined contributions: overcoming a non-participatory health care economy.

Authors:  Robert E Moffit
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718
  9 in total
  1 in total

1.  Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population.

Authors:  Ramez N Eskander; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Robert E Bristow
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.